The company in question is, DexCom, Inc. (NASDAQ:DXCM) currently with a stock price of 81.85 (-0.16% today). The market cap for DexCom, Inc. is 6889.6, and is in the sector Healthcare, and Medical Laboratories & Research industry. The target price for DexCom, Inc. is 97.51. Currently DexCom, Inc. is trading with a P/E of *TBA, and a forward P/E of 333.25. Average volume for DexCom, Inc. is 878.32 and so far today it is 497417.
Performance in the last year for DexCom, Inc. has been 8.67%. For EPS growth, DexCom, Inc. has seen a growth of -142.30%, and is looking to grow in the next year to 143.90%. More long term stats show that EPS growth has been 5.70% over the last five years and could be 32.50% for the next five years. DexCom, Inc. has seen sales growth quarter over quarter at 47.30%, with EPS growth quarter over quarter at -419.90%. The 20-day simple moving average is -9.24%, with the 200-day simple moving average coming to 8.88%.
Since the IPO date for DexCom, Inc. on the 4/14/2005, DexCom, Inc. has seen performance year to date to be 0.10%. With DexCom, Inc. trading at 81.85, the dividend yield is *TBA, and the EPS is -0.99.
So could DexCom, Inc., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 14.07 and the P/B is at 27.79. The P/cash is 59.6, with P/free cash flow at 850.57.
DexCom, Inc. ability to deal with debt shows that the current ratio is 3.3, and the quick ratio is 2.7. This is with long term debt/equity at 0, and total debt/equity at 0.
In terms of margins, DexCom, Inc. has a gross margin of 66.70%, an operating margin of -16.40% and a profit margin of -16.40%.Payout ratio for DexCom, Inc. is *TBA. Return on assets come to -27.20% with return on investment coming to -25.60%.
Insider ownership for DexCom, Inc., is at 1.90% and institutional ownership comes to 95.40%. Outstanding shares are at 84.04. While shares float is 82.56. The float short is currently 5.85%, and short ratio is 5.5.